255 related articles for article (PubMed ID: 24417932)
1. Serological assessment of measles-rubella vaccination catch-up campaign among university students.
Takeuchi J; Goto M; Kawamura T; Hiraide A
Pediatr Int; 2014 Jun; 56(3):395-9. PubMed ID: 24417932
[TBL] [Abstract][Full Text] [Related]
2. A measles and rubella (MR) catch-up vaccination campaign in an Egyptian University: vaccine uptake and knowledge and attitudes of students.
Abd Elaziz KM; Sabbour SM; Dewedar SA
Vaccine; 2010 Nov; 28(47):7563-8. PubMed ID: 20797454
[TBL] [Abstract][Full Text] [Related]
3. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
Zäch K; Nicoara C; Germann D; Matter L
Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
[TBL] [Abstract][Full Text] [Related]
4. A serosurvey evaluation of the school-based measles 'catch-up' immunisation campaign in Victorian school-aged children.
Riddell MA; Leydon JA; Ugoni A; Kelly HA
Aust N Z J Public Health; 2001 Dec; 25(6):529-33. PubMed ID: 11824989
[TBL] [Abstract][Full Text] [Related]
5. Progress in measles and rubella elimination in Iran.
Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a two-dose measles, mumps, and rubella vaccination schedule in a cohort of college athletes.
Coté TR; Sivertson D; Horan JM; Lindegren ML; Dwyer DM
Public Health Rep; 1993; 108(4):431-5. PubMed ID: 8341775
[TBL] [Abstract][Full Text] [Related]
7. Implementation and evaluation of a measles/rubella vaccination campaign in a campus university in the UK following an outbreak of rubella.
Stevenson J; Murdoch G; Riley A; Duncan B; McWhirter M; Christie P
Epidemiol Infect; 1998 Aug; 121(1):157-64. PubMed ID: 9747767
[TBL] [Abstract][Full Text] [Related]
8. Measles-rubella mass immunization campaign in Albania, November 2000.
Bino S; Kakarriqi E; Xibinaku M; Ion-Nedelcu N; Bukli M; Emiroglu N; Uzicanin A
J Infect Dis; 2003 May; 187 Suppl 1():S223-9. PubMed ID: 12721917
[TBL] [Abstract][Full Text] [Related]
9. [Antibody titers against measles, rubella, mumps and varicella-zoster viruses in medical students].
Yoshida N; Tsumura N; Toyomasu K; Sagawa K
Sangyo Eiseigaku Zasshi; 2007 Jan; 49(1):21-6. PubMed ID: 17303935
[TBL] [Abstract][Full Text] [Related]
10. Serological survey for rubella and measles antibodies among first graders.
Schiff GM; Linnemann CC; Shea L; Witte JJ; Ackerman JH; Stapleton L; Elsea WR; Agna M
JAMA; 1974 Jan; 227(1):49-52. PubMed ID: 4859626
[No Abstract] [Full Text] [Related]
11. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
Stohrer-Draxl P; Amstad H; Grize L; Gassner M; Takken-Sahli K; Bourquin C; Braun-Fahrländer C
Praxis (Bern 1994); 1999 Jun; 88(24):1069-77. PubMed ID: 10420798
[TBL] [Abstract][Full Text] [Related]
12. [Safety and efficacy in two-dose vaccination using measles and rubella combined (MR) vaccine].
Terada K; Ouchi K; Ihara T; Okada K; Numazaki K
Kansenshogaku Zasshi; 2008 Sep; 82(5):414-8. PubMed ID: 18975583
[TBL] [Abstract][Full Text] [Related]
13. Measles and rubella serosurvey identifies rubella immunity gap in young adults of childbearing age in Zambia: The added value of nesting a serological survey within a post-campaign coverage evaluation survey.
Hayford K; Mutembo S; Carcelen A; Matakala HK; Munachoonga P; Winter A; Wanyiri JW; Searle K; Mwansa FD; Mwiche A; Phiri C; Book C; Thuma PE; Moss WJ
Vaccine; 2019 Apr; 37(17):2387-2393. PubMed ID: 30905529
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of measles-rubella vaccination for mothers in early puerperal phase.
Hisano M; Kato T; Inoue E; Sago H; Yamaguchi K
Vaccine; 2016 Feb; 34(9):1208-14. PubMed ID: 26801065
[TBL] [Abstract][Full Text] [Related]
15. Impact of a Measles and Rubella Vaccination Campaign on Seroprevalence in Southern Province, Zambia.
Carcelen AC; Mutembo S; Matakala KH; Chilumba I; Mulundu G; Monze M; Mwansa FD; Moss WJ; Hayford K
Am J Trop Med Hyg; 2021 May; 104(6):2229-2232. PubMed ID: 33939639
[TBL] [Abstract][Full Text] [Related]
16. [Immune status against measles and rubella among 4 Chilean groups of different ages].
Valenzuela MT; Vega J; Leal I; Vicente M; Young V; Vera L; Fasce R; Ramírez E
Rev Med Chil; 1999 Mar; 127(3):359-65. PubMed ID: 10436723
[TBL] [Abstract][Full Text] [Related]
17. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].
Vázquez Fernández E; López Rois F; Vázquez Carrete JA; Gómez Tato B; Alvarez Ares M
An Esp Pediatr; 1987 Jul; 27(1):27-31. PubMed ID: 3662251
[TBL] [Abstract][Full Text] [Related]
18. [MR vaccine].
Nakayama T
Nihon Rinsho; 2011 Sep; 69(9):1573-8. PubMed ID: 21922755
[TBL] [Abstract][Full Text] [Related]
19. Nationwide campaign for vaccination of adults against rubella and measles--Costa Rica, 2001.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(44):976-9. PubMed ID: 11724151
[TBL] [Abstract][Full Text] [Related]
20. Progress toward measles elimination in Romania after a mass vaccination campaign and implementation of enhanced measles surveillance.
Pistol A; Hennessey K; Pitigoi D; Ion-Nedelcu N; Lupulescu E; Walls L; Bellini W; Strebel P
J Infect Dis; 2003 May; 187 Suppl 1():S217-22. PubMed ID: 12721916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
